Table 1
Patient characteristics
| Age, years | Sex, n, (%) | Treated tumors per patient, n | Tumor entity, n (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Min. | Mean (SD) | Median (IQR) | Max. | Male | Female | Median (IQR) | Max. | HCC | CRC | CCC | Other | |
| Patients (n = 192) | 15 | 65.03 (23.56) | 64.00 (57.75, 72.00) | 83 | 156 (81) | 36 (19) | 1.00 (1.00, 2.00) | 9 | 139 (72) | 29 (15) | 7 (4) | 17 (9) |
Table 2
Tumors treated using freehand and robotic guidance
| Ablation technique | Long axis, mm | Liver segment, n (%) | Device, n (%) | Primary efficacy, n (%) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Min | Mean (SD) | Max | I | II | III | IVa | IVb | V | VI | VII | VIII | Acculis | Emprint | Complete | Incomplete | |
| Freehand (n = 119) | 4 | 19.79 (12.42) | 85 | 1 (1) | 10 (8) | 16 (13) | 16 (13) | 9 (8) | 13 (11) | 17 (14) | 15 (13) | 22 (18) | 65 (55) | 54 (45) | 9 (76) | 28 (24) |
| Robotic guidance (n = 249) | 3 | 18.78 (10.78) | 64 | 6 (2) | 24 (10) | 20 (8) | 26 (10) | 16 (6) | 38 (15) | 36 (14) | 36 (14) | 47 (19) | 143 (57) | 106 (43) | 219 (88) | 30 (12) |
Table 3
Influence of tumor characteristics on primary efficacy
| Predictor | Estimate | Std.err | Wald | p-value | |
|---|---|---|---|---|---|
| Long axis, mm | ≤ 30 > 30 | Reference − 0.8717 | 0.3657 | 5.68 | 0.0171 |
| Guidance | Freehand Robotic | Reference 0.8064 | 0.3256 | 6.13 | 0.0133 |
| HCC | Reference | ||||
| Tumor entity | CRC CCC | 0.2922 0.0665 | 0.4483 0.6524 | 0.42 0.01 | 0.5145 0.9188 |
| Other | 0.0832 | 0.5228 | 0.03 | 0.8736 | |
| I | Reference | ||||
| II | − 0.3956 | 1.0798 | 0.13 | 0.7141 | |
| III | − 0.0449 | 1.1025 | 0.00 | 0.9675 | |
| IVa | 0.2688 | 1.1180 | 0.06 | 0.8100 | |
| Liver segment | IVb | − 0.2539 | 1.1597 | 0.05 | 0.8267 |
| V | 0.5961 | 1.1285 | 0.28 | 0.5974 | |
| VI | 0.9036 | 1.1736 | 0.59 | 0.4413 | |
| VII | 0.0656 | 1.1090 | 0.00 | 0.9528 | |
| VIII | − 0.1069 | 1.0929 | 0.01 | 0.9221 |